The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_004360.5(CDH1):c.1568A>G (p.Tyr523Cys)

CA090925

141014 (ClinVar)

Gene: CDH1
Condition: CDH1-related diffuse gastric and lobular breast cancer
Inheritance Mode: Autosomal dominant inheritance
UUID: 19eabdee-a252-43c4-a1f4-f09d37e205e2

HGVS expressions

NM_004360.5:c.1568A>G
NM_004360.5(CDH1):c.1568A>G (p.Tyr523Cys)
NC_000016.10:g.68819282A>G
CM000678.2:g.68819282A>G
NC_000016.9:g.68853185A>G
CM000678.1:g.68853185A>G
NC_000016.8:g.67410686A>G
NG_008021.1:g.86991A>G
ENST00000261769.10:c.1568A>G
ENST00000261769.9:c.1568A>G
ENST00000422392.6:c.1385A>G
ENST00000562836.5:n.1639A>G
ENST00000566510.5:c.*234A>G
ENST00000566612.5:c.1566-2719A>G
ENST00000611625.4:c.1631A>G
ENST00000612417.4:c.1568A>G
ENST00000621016.4:c.1568A>G
NM_004360.3:c.1568A>G
NM_001317184.1:c.1385A>G
NM_001317185.1:c.20A>G
NM_001317186.1:c.-254-2719A>G
NM_004360.4:c.1568A>G
NM_001317184.2:c.1385A>G
NM_001317185.2:c.20A>G
NM_001317186.2:c.-254-2719A>G

Benign

Met criteria codes 3
BS1 BS2 BP2_Strong
Not Met criteria codes 2
PM2 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen CDH1 Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 3.1

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
CDH1 VCEP
The filtering allele frequency of the c.1568A>G (p.Tyr523Cys) variant in the CDH1 gene is 0.15% for Latino/Admixed American chromosomes in gnomAD (95% CI of 23/15282), which meets the allele frequency threshold defined by the ClinGen CDH1 Variant Curation Expert Panel for considering strong evidence against pathogenicity for autosomal dominant hereditary diffuse gastric cancer variants (BS1). This variant has been observed in >10 individuals without a diagnosis of diffuse gastric cancer, signet ring tumor or lobular breast cancer and whose family histories do not suggest HDGC (BS2; internal laboratory contributors). This variant was observed in the homozygous state in 9 individuals without personal and/or family history of DGC, LBC, or SRC tumors (BP2_strong; internal laboratory contributors). In summary, the clinical significance of this variant is classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel: BS1, BS2, BP2_strong. (CDH1 VCEP specifications version 3.1; 06/26/2023)
Met criteria codes
BS1
The highest population minor allele frequency in gnomAD v3.1.2 is 0.001505 (23/15282 alleles) in the Latino/Admixed American population, which is higher than the ClinGen CDH1 VCEP threshold (>0.001) for BS1, and therefore meets this criterion (BS1)
BS2
This variant has been observed in 114 heterozygous and 9 homozygous individuals with no diffuse gastric cancer, signet ring cell carcinoma or lobular breast cancer and/or whose family histories do not suggest HDGC (BS2; GeneDX, Ambry, Invitae). Note that this includes seven individual with family history of unspecified gastric cancer. Three additional probands are known to have LBC.
BP2_Strong
This variant is observed in the homozygous state in 9 individuals without personal and/or family history of DGC, LBC, or SRC tumors (BP2; GeneDx and Invitae).
Not Met criteria codes
PM2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Approved on: 2023-08-03
Published on: 2023-08-03
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.